flupenthixol decanoate (Depixol)

01/01/1984 - "Therapeutic efficacy of flupenthixol decanoate in schizoaffective disorder: a clinical evaluation."
08/17/1971 - "[Preliminary study corncerning the treatment of chronic psychoses with Flupenthixol decanoate]."
09/01/1972 - "[Action of flupentixol decanoate in chronic psychoses of the schizophrenic type]."
06/10/2014 - "Flupenthixol decanoate (depot) for schizophrenia or other similar psychotic disorders."
01/01/2000 - "Depot flupenthixol decanoate for schizophrenia or other similar psychotic disorders."

11/01/2019 - "We aimed to estimate the effect of dose of flupentixol decanoate on relapse rates in schizophrenia and on tolerability by expanding on an earlier review and including non-RCT and German-language studies, as well as using pharmacokinetic and pharmacodynamic data to offer guidance on dosing. "
01/01/2000 - "From the data reported in clinical trials, it would be understandable if those suffering from schizophrenia, who are willing to take flupenthixol decanoate, would request the standard dose rather than the high dose. "
01/01/2021 - "Erratum: Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate."
01/01/2021 - "Extrapyramidal side effects in first-episode schizophrenia treated with flupenthixol decanoate."
11/01/2019 - "Estimating the optimal dose of flupentixol decanoate in the maintenance treatment of schizophrenia-a systematic review of the literature."

01/01/2000 - "Two small studies suggest that flupenthixol decanoate is responsible for less movement disorders than other depot antipsychotic drugs (OR 0.23 CI 0.08-0.7, NNT 5). "

12/01/2019 - "In this study treatment with flupenthixol decanoate was associated with relatively low levels of hyperprolactinemia, likely owing to flupenthixol's relatively atypical mode of action, as well as to the low doses used in our study. "

06/10/2014 - "To evaluate the effects of flupenthixol decanoate in comparison with placebo, oral antipsychotics and other depot neuroleptic preparations for people with schizophrenia and other severe mental illnesses, in terms of clinical, social and economic outcomes. "
01/01/2000 - "To evaluate the effects flupenthixol decanoate in comparison with placebo, oral antipsychotics and other depot neuroleptic preparations for people with schizophrenia and other severe mental illnesses, in terms of clinical, social and economic outcomes. "